Amanote Research
Register
Sign In
Treatment of Comorbid Anxiety and Depression With Escitalopram: Results of a Post-Marketing Surveillance Study
Pharmacopsychiatry
- Germany
doi 10.1055/s-0032-1311627
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Psychiatry
Mental Health
Pharmacology
Date
May 30, 2012
Authors
G. Laux
M. Friede
W. Müller
Publisher
Georg Thieme Verlag KG
Related search
Post-Marketing Surveillance
The Lability of Behavior as a Marker of Comorbid Depression and Anxiety
Advances in Bioscience and Biotechnology
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Cardiology and Therapy
Treatment of Comorbid Anxiety and Autism Spectrum Disorders
Neuropsychiatry
Psychiatry
Mental Health
Neurology
Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment With a Prospective Post-Marketing Surveillance Study
Drugs - Real World Outcomes
Pharmacology
Relationship of Anxiety and Preoperative Depression With Post-Operative Pain
Texto e Contexto Enfermagem
Nursing
Safety and Efficacy of Rapamune® (Sirolimus) in Kidney Transplant Recipients: Results of a Prospective Post-Marketing Surveillance Study in Korea
BMC Nephrology
Nephrology
Safety of Sublingual Immunotherapy With Monomeric All_ergoid in Adults: Multicenter Post-Marketing Surveillance Study
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
Safety and Efficacy of a Non-Steroidal Anti-Androgen, Based on Results of a Post Marketing Surveillance of Nilutamide
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
